What is the recommended management for a reproductive‑age woman with polycystic ovary syndrome, including lifestyle modification, hormonal therapy, insulin‑sensitizing agents, anti‑androgen treatment, and fertility options?

PCOS Management

Multicomponent lifestyle intervention including diet, exercise, and behavioral strategies is the first-line management for all women with PCOS, regardless of weight status, with combined oral contraceptive pills as first-line pharmacotherapy for menstrual irregularity and hyperandrogenism in those not seeking pregnancy. 1

First-Line Management: Lifestyle Modification

Lifestyle intervention is positioned at the top of the treatment hierarchy for PCOS and should be implemented before or alongside any pharmacological therapy. 1

Exercise Recommendations

• For weight maintenance: 150+ minutes per week of moderate activity OR 75+ minutes per week of vigorous activity, plus weight training 2x per week 1
• For weight loss: 300+ minutes per week of moderate activity OR 150+ minutes per week of vigorous activity 1
• Target heart rate should be 70-90% of maximum (calculated as 220 minus age) 1
• Both aerobic and resistance exercise enhance insulin sensitivity and improve metabolic and reproductive outcomes 2

Dietary Approach

• No single specific diet is superior, but focus on low glycemic index foods, high fiber intake, omega-3 fatty acids, Mediterranean diet patterns, and anti-inflammatory foods 1, 2
• Caloric restriction for weight loss in those with excess weight 2
• Reduce sugar-sweetened beverages and fruit juices 1
• Portion control is essential 1

Weight Management

• Prevention of weight gain is critical: Women with PCOS gain weight significantly faster than unaffected women, with accelerated weight gain from adolescence onward 1
• Monitor weight and waist circumference regularly 1
• Even modest weight loss (5-10%) improves reproductive, metabolic, and psychological outcomes 1
• Obesity exacerbates all features of PCOS including insulin resistance, hyperandrogenism, and psychological comorbidities 1

Pharmacological Management for Non-Fertility Goals

Menstrual Irregularity and Endometrial Protection

• Combined oral contraceptive pills (OCPs) are first-line treatment for menstrual cycle regulation and provide endometrial protection against hyperplasia 3, 4
• Use low-dose OCP preparations to minimize side effects 5
• Progestin-only pills or cyclical progestins are second-line for women with contraindications to OCPs 3

Hyperandrogenism (Hirsutism, Acne)

• OCPs are first-line for dermatologic manifestations 3, 4
• Anti-androgen drugs (spironolactone, finasteride, flutamide) added to OCPs for more severe hirsutism 3, 6
• Cosmetic procedures (laser therapy, electrolysis) provide more permanent hair reduction 6
• Topical agents for acne management 6

Metabolic Management

• Metformin is first-line for metabolic manifestations including hyperglycemia, insulin resistance, and can be considered for menstrual cycle regulation in women with insulin resistance and dysglycemia 3, 4
• Screen regularly for type 2 diabetes (PCOS patients are 4x more likely to develop diabetes), dyslipidemia, hypertension, and metabolic syndrome 4, 7
• Statins for dyslipidemia when indicated 3
• Consider anti-obesity medications in appropriate candidates 3
• Bariatric surgery may be considered for severely obese women with PCOS 3

Fertility Management

First-Line Ovulation Induction

• Clomiphene citrate remains the established first-line treatment for ovulation induction 8, 4
• Letrozole (aromatase inhibitor) is also first-line for infertility 4
• Weight loss in overweight women improves ovulation rates 8, 6

Second-Line Options

• Exogenous gonadotropins for clomiphene-resistant patients 8, 3
• Laparoscopic ovarian drilling is an alternative to gonadotropins, particularly in patients requiring laparoscopy for other indications 8, 3
• Metformin can be used adjunctively but is no longer recommended as monotherapy for ovulation induction 3

Assisted Reproductive Technology

• In vitro fertilization (IVF) is indicated for anovulatory patients who fail other treatments or have additional infertility factors 8

Screening and Long-Term Health Planning

Metabolic Screening

• Screen for type 2 diabetes, impaired glucose tolerance, dyslipidemia, and hypertension 4, 7
• PCOS is now recognized as a cardiovascular disease risk-enhancing factor with increased risk of myocardial infarction and stroke even in reproductive years 7
• Screen for nonalcoholic fatty liver disease 6
• Evaluate for sleep apnea, which occurs more commonly in PCOS 6

Psychological Health

• Screen for depression, anxiety, eating disorders, body image concerns, and low self-esteem 1, 6
• Address weight stigma respectfully during assessment 1
• Provide psychological support as part of comprehensive care 6

Key Clinical Pitfalls

• Do not use polycystic ovarian morphology on ultrasound or anti-Müllerian hormone levels for diagnosis in adolescents 5
• Do not delay endometrial protection: Irregular cycles require hormonal contraception, progestin therapy, or weight loss to prevent endometrial hyperplasia 6
• Do not overlook cardiovascular risk: PCOS requires lifelong cardiovascular screening and risk modification 7
• Evaluate rapidly progressive virilization immediately for potential androgen-secreting tumors 4
• Weight management discussions must balance health risks with minimizing weight stigma 5